Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: SAVA

Group By Ticker
Sort By
Newest | Oldest
Read More
6 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

71 Biggest Movers From Yesterday

By Lisa Levin
November 3, 3:33 AM
Gainers Avis Budget Group, Inc. (NASDAQ: CAR) shares climbed 108.3% to close at $357.17 on Tuesday after the company reported better-than-expected Q3 adjusted EPS and sales results and added $1 billion to its buyback.

ABVC

Read More
1 minute read
  • Pre-Market Outlook

Top 10 WallStreetBets Trending Stocks For Afternoon Of Tuesday, Nov. 2, 2021

By Benzinga Newsdesk
November 2, 5:47 PM
Bed Bath & Beyond (BBBY) GameStop (GME) AMC Entertainment (AMC) Tesla (TSLA) Activision Blizzard (ATVI) Avis Budget Group (CAR) Ocugen (OCGN) Advanced Micro Device (AMD) Chegg (CHGG) Cassava Sciences

AMC

Read More
1 minute read
  • Legal
  • Movers
  • News
  • Trading Ideas

Cassava Sciences Shares Move Lower; Helios Capital Shares Screenshot Of An SEC FOIA Filing. BZ NOTE: Benzinga Cannot Verify The Authenticity Of The Contents

By Benzinga Newsdesk
October 20, 12:38 PM
https://twitter.com/helioscap/status/1450861080696197133

SAVA

Read More
3 minute read
  • Commodities
  • Markets
  • Small Cap

It Turns Out That The World Still Needs Coal: Good News For Our Recent Top Name, Peabody Energy

By David Pinsen
October 19, 3:29 PM
A Liebherr mining truck at dusk at Peabody's North Antelope Rochelle Mine in the Powder River Basin of Wyoming (photo via Peabody).  It Turns Out The World Still Needs Coal Readers may remember President Biden ran on shutting down coal mining as part of his overall campaign against fossil fuels. 

BOIL

Read More
2 minute read
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Crisis Investing: From COVID, To Energy, To Supply Chain Breakdowns, The Market Has Been Buffeted By Crises Recently. How We’ve Navigated Them So Fa.

By David Pinsen
October 12, 11:01 AM
A Gadsden flag hung out of a Southwest Airlines 737 cockpit. Photo via American Greatness.  A Market Buffeted By Bad News

BOIL

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

Cassava Sciences Starts Late-Stage Simufilam Study In Alzheimer’s Patients

By Vandana Singh
October 6, 12:31 PM
Cassava Sciences Inc (NASDAQ:SAVA) initiated an initial Phase 3 efficacy study of simufilam, an investigational drug for patients with Alzheimer’s disease. …

SAVA

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Small Cap

Rebuilding Connections, Fostering Growth: Synaptogenix Could Be A Beacon of Hope for Patients With Neurological Diseases

By Emily Cervone
October 5, 9:14 AM
Image by Gerd Altmann from Pixabay 

ATHA

Read More
2 minute read
  • Biotech
  • General
  • Long Ideas
  • Markets
  • News
  • Short Ideas
  • Trading Ideas

How David Green Traded Moderna For A Big Profit On Monday Morning

By Spencer Israel
October 4, 11:27 AM
David Green was back live trading on Benzinga TV on Monday morning. Here's a recap of what he traded and discussed.

BNTX

Read More
1 minute read
  • FDA
  • News

Cassava Sciences Sponsored Study Titled ‘Simufilam 100 mg for Mild-to-Moderate Alzheimer’s Disease (RETHINK-ALZ)’ Posted To ClinicalTrials.Gov; Study Is Recruiting

By Benzinga Newsdesk
September 29, 8:28 AM
https://www.clinicaltrials.gov/ct2/show/NCT04994483?term=Simufilam&draw=2&rank=2

SAVA

Read More
1 minute read
  • Biotech
  • General

‘$SAVA — Yale was removed as a participating enrollment center for the company’s simufilam REFOCUS-ALZ Phase 3 study.’ -STAT Reporter

By Bill Haddad
September 28, 7:43 AM
https://twitter.com/adamfeuerstein/status/1442815799618584576

SAVA

Posts navigation

Previous 1 … 13 14 15 … 25 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service